Breaking

First-of-Its-Kind Treatment Shown to Have a 'Dramatic' Effect on Kids With Eczema - ScienceAlert
Sep 21, 2022 53 secs

There's currently no cure for the condition, just ways of managing it – but an existing drug is incredibly effective at reducing the signs and symptoms of eczema in kids under six with moderate to severe cases of the disorder.

In a new study, 162 North American and European kids between the ages of 6 months and 6 years with moderate-to-severe eczema were given dupilumab or a placebo across the course of 16 weeks.

Dupilumab targets an important immune inflammation pathway in allergies and is already used to treat eczema in older children and adults, as well as asthma, nasal polyps, and other allergy-mediated problems.

Around a third of this age group with eczema have a moderate to severe case of the disorder, with accompanying itchiness that is debilitating: These kids can't sleep properly, which has all kinds of knock-on effects and consequences.

While immune-suppressing medications such as oral steroids are often used for severe cases of eczema, there are concerns over their suitability for young children – both in terms of the short-term side effects and the long-term health complications, according to Paller.

RECENT NEWS

SUBSCRIBE

Get monthly updates and free resources.

CONNECT WITH US

© Copyright 2024 365NEWSX - All RIGHTS RESERVED